Haddose Pharmaceuticals Private Limited - Company Profile

It is a chemicals private limited company based in Calicut, Kerala, India, established in 2015.
2015 Calicut, Kerala, India Struck Off
Last Updated:
Access Report
About Haddose Pharmaceuticals Private Limited

Haddose Pharmaceuticals Private Limited, a struck off private limited company, was established on 19 May 2015 in Calicut, Kerala, India. Engaging in manufacturing within the chemicals sector, it holds CIN: U24230KL2015PTC038499. Registered under ROC Roc Ernakulam. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

Its leadership includes Riyaz Mohammed Rafique (Director), Shaji Koorkkapparamba (Director), Mundani Suhanesh Haridas (Director). It is based at Op 8/772 L, Kunnathupalam Olavanna Po, Calicut, Kerala, 673014.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24230KL2015PTC038499

  • Registration Number

    038499

  • Incorporation Date

    19 May 2015

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Ernakulam

  • Listing Status

    Unlisted

  • Company Status

    Struck Off

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 11 Year, 21 Days
Company report

Haddose Pharmaceuticals Private Limited

Company Report FY 2026-2027

Comprehensive Company Insights

Explore comprehensive insights into Haddose Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Haddose Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Riyaz Mohammed Rafique Director 19 May 2015 Current
Shaji Koorkkapparamba Director 19 May 2015 Current
Mundani Suhanesh Haridas Director 19 May 2015 Current
Hafis Punathilparamda Director 19 May 2015 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Haddose Pharmaceuticals.

Enhance accessibility to Haddose Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Haddose Pharmaceuticals revenue growth over time
Haddose Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Haddose Pharmaceuticals?

Unlock access to Haddose Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Haddose Pharmaceuticals?

Unlock and access historical data on people associated with Haddose Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Haddose Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Haddose Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Haddose Pharmaceuticals
Recent Activity within the Organization
  • Director Appointment

    Progress on Riyaz Mohammed Rafique was appointed as a Director was appointed as a Director on 19 May 2015 & has been associated with this company since 11 years 21 days . was documented.

  • Director Appointment

    The activity Shaji Koorkkapparamba was appointed as a Director was appointed as a Director on 19 May 2015 & has been associated with this company since 11 years 21 days . was completed.

  • Director Appointment

    The activity Mundani Suhanesh Haridas was appointed as a Director was appointed as a Director on 19 May 2015 & has been associated with this company since 11 years 21 days . was completed.

  • Director Appointment

    The activity Hafis Punathilparamda was appointed as a Director was appointed as a Director on 19 May 2015 & has been associated with this company since 11 years 21 days . was completed.

  • Company Incorporation

    Progress on Haddose Pharmaceuticals Private Limited was registered on 19 May 2015 with Roc Ernakulam & aged 11 years 21 days as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Haddose Pharmaceuticals Private Limited?

The CIN of Haddose Pharmaceuticals Private Limited is U24230KL2015PTC038499.

Where is Haddose Pharmaceuticals Private Limited headquartered?

Haddose Pharmaceuticals Private Limited is headquartered at Op 8/772 L, Kunnathupalam Olavanna Po, Calicut, Kerala, 673014.

When was Haddose Pharmaceuticals Private Limited incorporated?

Haddose Pharmaceuticals Private Limited was incorporated on 19 May 2015.

Who are the current directors of Haddose Pharmaceuticals Private Limited?

The current directors of Haddose Pharmaceuticals Private Limited are

What is the primary industry of Haddose Pharmaceuticals Private Limited?

The primary industry of Haddose Pharmaceuticals Private Limited is Chemicals.

Is Haddose Pharmaceuticals Private Limited a listed company?

Haddose Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Haddose Pharmaceuticals Private Limited?

The authorized capital of Haddose Pharmaceuticals Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available